Contenu disponible en anglais seulement.
Bulletin de la Bourse
BMO ARK Genomic Revolution Fund (ARKG) inscrit à la Bourse de Toronto
15 novembre 2022
Issuer: BMO ARK Genomic Revolution Fund (the "ETF")
| Security | Symbol | Issued and Outstanding Securities | Reserved Securities | Issue Price |
|---|---|---|---|---|
| ETF Series Units (the "Units") | ARKG | 100,000 | None | $15 |
| Listing category: | Non-Corporate |
| Trading currency: | CDN$ |
| Transaction: | Initial public offering of Units (the "Offering") |
| Anticipated closing date: | November 17, 2022 |
| Listing date: | November 16, 2022 (as at 5:01 pm) in anticipation of closing of the Offering. |
| Posted for trading date: | November 17, 2022 (at the opening) subject to confirmation of closing of the Offering. |
| Other market(s): | None |
| Designated market maker: | BMO Nesbitt Burns Inc. |
| Investor relations: | Kevin Gopaul Head of Exchange Traded Funds, BMO Investments Inc. 416-359-7635 kevin.gopaul@bmo.com |
| Incorporation: | The ETF was established as a trust under the laws of the Province of Ontario pursuant to an amended and restated master declaration of trust dated November 1, 2022. |
| Manager and Trustee: | BMO Investments Inc. |
| Fiscal year end: | September 30 |
| Nature of business: | The ETF's objective is to provide long-term capital growth by investing primarily in equity securities of companies involved in disruptive genomic innovation from around the world. |
| Transfer agent and registrar: | State Street Trust Company Canada at its principal offices in Toronto. |
| Distributions: | Cash distributions on Units of the ETF, if any, are expected to be made on an annual basis. |
| Sponsorship: | Not applicable |
| Offering document: | Simplified Prospectus dated November 1, 2022, which is available at www.SEDAR.com. Capitalized terms not otherwise defined herein are as defined in the Prospectus. |
| Initial public offering: | 100,000 Units will be issued at a subscription price of $15.00 per Unit. Units are being issued and sold on a continuous basis and there is no maximum number of Units that may be issued. |
| TSX contact: | Selma Thaver, Director, TSX Listings |